Specifically, SH3GL2 mutations are associated with the impairment in synaptic vesicle endocytosis prior to loss of dopaminergic neurons, therefore representing a significant contributor to PD pathogenesis [71]. The gene discussed is SH3GL2; the disease is Parkinson disease.